Back

Assessing the CHA2DS2-VASc score in risk stratification and management of oral anticoagulation during TAVI

31 August 2025 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Bleedings and conduction disturbances after aortic interventions Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Dirk Jan van Ginkel

St Antonius Hospital, Nieuwegein (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Bleeding risk in all-comer TAVI patients
Mrs S. Baleswaran Krishnapillai (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Impact of packed red blood cells administration on long-term outcomes in patients undergoing transcatheter aortic valve implantation
Doctor T. Stolte (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Bleeding risk stratification in patients undergoing transcatheter aortic valve replacement: enhancing VARC-HBR criteria with CT-ADP as a marker of primary hemostatic disorder
Doctor S. Kikuchi (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Impact of short membranous septal length on overall survival after transcatheter aortic valve replacement
Doctor H. Tsurumi (Okinawa, JP)
Abstract Slides Video
Presentation thumbnail
The impact of persistent LBBB After TAVI: unraveling its effect on cardiac function and survival
Doctor A. Lobo (Vila Nova de Gaia, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Bleedings and conduction disturbances after aortic interventions

The Event

Event poster

ESC Congress 2025

31 August 2025 14:15 CET
You may be interested in
thumbnail
Congress Session
HOT LINE 5
thumbnail
Congress Presentation
Atrial fibrillation and TAVI or bioprosthetic heart valves: who and how to anticoagulate
thumbnail
Congress Session
Predictors of TAVI outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources